Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Affymax and Takeda Report Phase 2 Analyses of Hematide/peginesatide in Hemodialysis Patients
Affymax and Takeda Report Phase 2 Analyses of Hematide/peginesatide in Hemodialysis Patients
Affymax and Takeda Report Phase 2 Analyses of Hematide/peginesatide in Hemodialysis Patients
Submitted by
admin
on April 17, 2010 - 12:58pm
Source:
PharmaLive
News Tags:
Affymax
Takeda
Hematide/peginesatide
dialysis
Headline:
Affymax and Takeda Report Phase 2 Analyses of Hematide/peginesatide in Hemodialysis Patients
Do Not Allow Advertisers to Use My Personal information
